Home | Founder | What's New | In The News | Contact Us | |||||||
Paradigm Shift Intervention Monitoring |
Patents Recombinomics,
Inc. Founder and President Henry L Niman, PhD has filed patents
covering use of
viral recombination in: vaccine development 20090232842
Indentifying and Predicting Infleunza Variants and Uses Thereof 20070253978
Copy Choice Recombination and Uses Thereof WO/2008/091659
Methods and Compositions for Predicting and Treating Drug Resistant
Strains of Influenza Virus WO/2007/008605
Identifying and Predicting Influenza Variants and Uses Thereof WO/2006/033691
A2 Copy Choice Recombination and Uses Thereof Dr. Niman has
been issued patents covering: coupling monoclonal antibody and
synthetic peptide technologies Issued United
States Patents 6,551,789 Process for characterizing a biological
sample using patterns of oncogene expression 5,985,587
Polypeptide-induced
monoclonal
receptors to protein ligands 5,972,629 Method for characterizing antigenic
reactivity of biological sample 5,786,178 Polypeptide-induced
monoclonal
receptors to protein ligands 5,733,738 Polypeptide-induced
monoclonal
receptors to protein ligands 5,591,587
Polypeptide-induced
monoclonal
receptors to protein ligands 5,563,247 Monoclonal
antibodies to oncoproteins
and methods of making monoclonal antibodies 5,030,565
Polypeptide-induced
monoclonal
receptors to protein ligands 5,015,571 Polypeptide-induced monoclonal receptors to protein ligands |
||||||||||
Webmaster:
webmaster@recombinomics.com
© 2007
Recombinomics. All
rights
reserved.